The safety and effectiveness of vonoprazan-based Helicobacter pylori eradication therapy; a prospective post-marketing surveillance.
Conclusion: No new safety concerns were observed, and the effectiveness of vonoprazan-based triple therapy was confirmed in routine clinical practice. Trial registration: This study is registered at the Japan Pharmaceutical Information Center Clinical Trials Information (JapicCTI-153003).
PMID: 31646920 [PubMed - as supplied by publisher]
Source: Expert Opinion on Drug Safety - Category: Drugs & Pharmacology Tags: Expert Opin Drug Saf Source Type: research
More News: Amoxicillin | Biaxin | Cancer | Cancer & Oncology | Clarithromycin | Clinical Trials | Drugs & Pharmacology | Duodenal Ulcer | Gastric (Stomach) Cancer | Gastric Ulcer | Gastritis | Gastroenterology | Helicobacter Pylori | Japan Health | Metronidazole | Study